<DOC>
	<DOCNO>NCT01165268</DOCNO>
	<brief_summary>It anticipate 7 day oral administration 10 mg dapagliflozin reduce renal glucose reabsorption similarly healthy subject subject T2DM .</brief_summary>
	<brief_title>Characterization Kinetics Renal Glucose Reabsorption Response Dapagliflozin Healthy Subjects Subjects With Type 2 Diabetes Mellitus ( T2DM )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion criterion T2DM Diagnosis T2DM Must one follow therapy : diet therapy alone , diet plus sulfonylurea , diet plus metformin , diet plus sulfonylurea plus metformin Subjects take metformin , and/or sulfonylurea must stable dose least 2 month prior study drug administration Must fast plasma glucose concentration ≤ 200 mg/dl , HbA1C ≤ 10 % Inclusion criterion healthy subject : Healthy subject ( determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination ) Inclusion criterion subject : Subjects ( eGFR ≥ 60 ≤ 160 mL/min/1.73m² urinary albumin excretion &lt; 300 mg/g creatinine ) Body Mass Index ( BMI ) 18 38 kg/m² Men woman , age 18 65 year , inclusive Exclusion criterion subject : Subjects Type 1 Diabetes uncontrolled Type 2 Diabetes Mellitus Subjects T2DM fast plasma glucose &gt; 200 mg/dL , healthy subject fast plasma glucose &gt; 105 mg/dL Subjects T2DM HbA1C &gt; 10.0 % , healthy subject HbA1C &gt; 6.8 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>